Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laboratory Corporation Of America Holdings (LH)
NYSE:LH
Laboratory (LH) Stock Price & Analysis
968 Followers
LH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$177.78 - $233.32
Previous Close$199.45
Volume769.00K
Average Volume (3M)737.17K
Market Cap
$16.77B
Enterprise Value$22.19B
Total Cash (Recent Filing)$536.80M
Total Debt (Recent Filing)$5.95B
Price to Earnings (P/E)41.8
Beta0.90
Next Earnings
Apr 25, 2024EPS Estimate
$3.48Next Dividend Ex-Date
May 24, 2024Dividend Yield1.44%
Share Statistics
EPS (TTM)4.65
Shares Outstanding84,100,000
10 Day Avg. Volume695,222
30 Day Avg. Volume737,173
Standard Deviation0.08
R-Squared0.40
Alpha-0.00181
Financial Highlights & Ratios
Price to Book (P/B)-10.55
Price to Sales (P/S)7.33
Price to Cash Flow (P/CF)7.30
P/FCF Ratio6.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.82
Enterprise Value/Gross Profit6.59
Enterprise Value/Ebitda15.01
Forecast
1Y Price Target
$243.56Price Target Upside22.12% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Laboratory News
PremiumCompany Announcements
Laboratory Corp Announces Upcoming Cash Dividend Payout
PremiumPress Releases
Labcorp Declares Quarterly Dividend
PremiumCompany Announcements
Labcorp Announces Q1 2024 Earnings Call and WebcastBulls Say, Bears Say
Bulls Say
Acquisition StrategyManagement continues to pursue accretive acquisitions, enhancing the company's service offerings and operational footprint.
Financial PerformanceSolid organic clinical lab base business trends and margin improvements in the biopharma lab services are likely to enhance profitability.
Growth ProspectsAnalyst reiterates Buy rating based on strong growth trends in the core business and potential for margin improvement.
Bears Say
Financial PerformanceFree cash flow in 2024 significantly declined due to lower COVID testing earnings and other factors.
Operational ChallengesEarly Development segment faces challenges with elevated cancellations due to a tough funding environment for smaller biotech clients.
Regulatory ConcernsThere's a near-term overhang on the stock related to an expected release of rules related to lab-developed tests (LDTs).
---
Ownership Overview
1.47% Insiders
29.75% Mutual Funds
23.90% Other Institutional Investors
44.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Laboratory Corporation Of America Holdings’s price range in the past 12 months?
Laboratory Corporation Of America Holdings lowest stock price was $177.78 and its highest was $233.32 in the past 12 months.
What is Laboratory Corporation Of America Holdings’s market cap?
Currently, no data Available
When is Laboratory Corporation Of America Holdings’s upcoming earnings report date?
Laboratory Corporation Of America Holdings’s upcoming earnings report date is Apr 25, 2024 which is in 6 days.
How were Laboratory Corporation Of America Holdings’s earnings last quarter?
Laboratory Corporation Of America Holdings released its earnings results on Feb 15, 2024. The company reported $3.3 earnings per share for the quarter, beating the consensus estimate of $3.257 by $0.043.
Is Laboratory Corporation Of America Holdings overvalued?
According to Wall Street analysts Laboratory Corporation Of America Holdings’s price is currently Undervalued.
Does Laboratory Corporation Of America Holdings pay dividends?
Laboratory Corporation Of America Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.44%. See more information on Laboratory Corporation Of America Holdings dividends here
What is Laboratory Corporation Of America Holdings’s EPS estimate?
Laboratory Corporation Of America Holdings’s EPS estimate is $3.48.
How many shares outstanding does Laboratory Corporation Of America Holdings have?
Laboratory Corporation Of America Holdings has 84,100,000 shares outstanding.
What happened to Laboratory Corporation Of America Holdings’s price movement after its last earnings report?
Laboratory Corporation Of America Holdings reported an EPS of $3.3 in its last earnings report, beating expectations of $3.257. Following the earnings report the stock price went down -2.621%.
Which hedge fund is a major shareholder of Laboratory Corporation Of America Holdings?
Among the largest hedge funds holding Laboratory Corporation Of America Holdings’s share is Diamond Hill Capital Management Inc. It holds Laboratory Corporation Of America Holdings’s shares valued at 324M.
---
Laboratory Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$243.56 (22.12% Upside)
$243.56 (22.12% Upside)
Blogger Sentiment
Bullish
LH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 77.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.91%
12-Months-Change
Fundamentals
Return on Equity
4.27%
Trailing 12-Months
Asset Growth
-17.02%
Trailing 12-Months
Company Description
Laboratory Corporation Of America Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
---
LH Company Deck
---
LH Earnings Call
Q4 2024
0:00 / 0:00
---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Months Forecast
Average Price Target
$243.56
▲(22.12% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
14/17 ratings generated profit
1 Year Average Return
+15.29%
reiterated a buy rating 9 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 82.35% of your transactions generating a profit, with an average return of +15.29% per trade.
---